Purpose: Diabetic retinopathy (DR) can lead to significant vision loss and blindness and has a particularly high prevalence in patients with type 1 diabetes (DM1). In this study, we investigate quantitative differences in optical coherence tomography angiography (OCTA) data between DM1 patients with no or mild signs of retinopathy and non-diabetic subjects. Methods: Optical coherence tomography angiography (OCTA) imaging was performed on DM1 patients with no or mild nonproliferative diabetic retinopathy and healthy, age-matched controls. Parafoveal vessel density and foveal avascular zone (FAZ) area in the deep capillary plexus (DCP) and superficial capillary plexus (SCP) were calculated with automated quantification software and compared between patient cohorts. Results: A significant decrease in parafoveal vessel density was seen in the DCP of DM1 patients compared to non-diabetic controls (57.0 AE 3.3% versus 60.7 AE 2.4%, p < 0.001). There was no significant difference in SCP parafoveal vessel density, DCP FAZ area, or SCP FAZ area between cohorts. Conclusion: M1 patients with no or mild signs of retinopathy have reduced parafoveal vessel density in the DCP on OCTA when compared to non-diabetic controls. These OCTA findings suggest that parafoveal capillary nonperfusion is an early process in DM1-related retinal changes and occurs initially at the level of the DCP. Further investigation is needed to understand the prognostic role of these vascular changes.
Introduction
Diabetic retinopathy (DR), one of the most common microvascular complications of type 1 diabetes mellitus (DM1), is characterized by capillary nonperfusion, vessel hyperpermeability, and neovascularization (Frank 2004; Roy et al. 2004 ). Progression of these pathophysiologic changes can ultimately result in macular oedema and proliferative diabetic retinopathy, which cause the majority of significant DR-related vision loss (Antonetti et al. 2012) . Ophthalmoscopy and colour fundus photography have been considered the gold standard for the diagnosis and staging of DR; however, the occurrence of microvascular damage, including pericyte loss and capillary leakage and nonperfusion, is known to occur before findings of retinopathy become apparent on clinical examination or fundus photography (Hammes 2005; Durham & Herman 2011) . Optical coherence tomography (OCT) and the development of automated retinal layer segmentation algorithms have allowed for detection of early retinal morphological changes in patients with preclinical or early DR (van Dijk et al. 2009; Vujosevic & Midena 2013; Chen et al. 2015) .
Fluorescein angiography (FA) has long been an important imaging modality in the management of DR and in the diagnosis of diabetic macular ischaemia (ETDRS G 1991a,b) . Diabetic macular ischaemia, which is defined as an enlargement of the foveal avascular zone (FAZ) and capillary nonperfusion in the paramacular areas, has been associated with decreased visual function and progression to neovascular complications (Sim et al. 2013; Ip et al. 2015) . With the more recent development of Optical coherence tomography angiography (OCTA), abnormalities in retinal blood flow can now be assessed and quantified noninvasively (Yu & Chen 2010; Jia et al. 2012 Jia et al. , 2015 Nemiroff et al. 2016) .
In addition, OCTA facilitates individual analyse of the distinct vascular layers of the retina, namely the superficial (SCP) and deep capillary plexuses (DCP) (Ishibazawa et al. 2015; Yu et al. 2015) . Using OCTA, multiple clinical studies have now described retinal blood flow changes in the posterior pole of diabetic patients, including the presence of microaneurysms, capillary nonperfusion, and neovascularization (Freiberg et al. 2016; Hwang et al. 2015 Hwang et al. , 2016a Ishibazawa et al. 2015) . This non-invasive imaging has also been applied to diabetic eyes with no or mild retinopathy with the goal of identifying the earliest diabetic-associated blood flow changes; studies have reported foveal avascular zone (FAZ) enlargement in these populations Takase et al. 2015; Cennamo et al. 2016) .
While many studies have investigated vascular changes in DR, few have focused on the earliest retinal changes in DM1 patients. The aim of this study was to investigate microvascular retinal changes, using automated, quantitative measurements from OCTA data, in DM1 patients with no or mild clinical signs of DR.
Patients and Methods

Subjects
This cross-sectional observational case-control clinical study was performed according to the Declaration of Helsinki, and informed consent was obtained from all study participants. DM1 and healthy control subjects were included. Only data from the right eye was analysed. Enrolment criteria included a diagnosis of DM1 made at least 1 year prior to study enrolment and age ≥18 years. Exclusion criteria included bad metabolic control (HbA1c > 9%), evidence of macular oedema on clinical examination or OCT macular B-scan, high myopia (<À6.00 dioptres), lens opacity that could affect imaging, and history of any other retinal disease or intraocular surgery.
The diagnosis of DR was based on a comprehensive medical and ophthalmic history and full ophthalmologic examination, including best-corrected visual acuity (BCVA), external slit lamp examination, and ophthalmoscopy. Two experienced examiners (MP and MV), based on the analysis of colour fundus photographs, classified the eye as no DR (no abnormalities) or mild nonproliferative DR (NPDR) according to the modified Early Treatment Diabetic Retinopathy Study (ETDRS) retinopathy severity scale and analysed the B-scan OCT images to exclude the presence of oedema (ETDRS G 1991a,b) .
Image collection and analysis
Optical coherence tomography angiography (OCTA) images were obtained using the prototype ANGIOVUE OCTA software of the commercially available RTVue XR spectral domain OCT device (Optovue, Inc., Fremont, CA, USA). This instrument has an A-scan rate of 70 000 scans per second and uses a light source centred on 840 nm and a bandwidth of 45 nm. A splitspectrum amplitude-decorrelation angiography (SSADA) algorithm, explained in detail elsewhere (Jia et al. 2012) , was used to detect erythrocyte movement and depict blood flow in a 3 9 3 mm scanning area centred on the fovea. Low-quality OCTA images, defined as signal strength index below 50 or presence of motion artefacts, were excluded from the study.
En face OCT angiograms were segmented to define the superficial capillary plexus (SCP) and DCP, using the built-in software segmentation algorithm. The SCP slab was taken from the internal limiting membrane to the inner plexiform layer/inner nuclear layer interface. The DCP slab was taken from the inner plexiform layer/ inner nuclear layer interface to the outer plexiform layer/outer nuclear layer interface. The 'parafovea' was defined as the area within an annulus centred on the fovea with inner and outer ring diameters of 1 and 2.5 mm, respectively (Fig. 1) . Parafoveal vessel density, defined as the percentage of total area occupied by vessels and microvasculature, was quantified in the SCP and DCP. To calculate vessel density, the ANGIOVUE ANALYTICS software was used to extract a binary image of the blood vessels from the grey scale OCTA image and then calculate the percentage of pixels with flow signal above the preset decorrelation threshold in the defined region.
Foveal avascular zone area was measured using the 'NO FLOW' software function in both superficial and deep capillary plexuses.
Statistical analysis
All statistical evaluation was performed using SPSS software (version 17.0; SPSS Inc., Chicago, IL, USA). Data were expressed as mean AE SD. Data were confirmed to be normally distributed with Shapiro-Wilk test, and independent, two-tailed Student's t-tests were applied to compare data samples. Pearson correlation coefficients were calculated to assess correlations between disease duration, HbA1c, and vessel density. p-Value ≤0.05 was considered statistically significant.
Results
Patients
Twenty-eight DM1 and 23 healthy control subjects were included. There was no statistical difference in age (42.3 AE 8.6 versus 39.6 AE 10.1, p = 0.33) or gender (54% versus 57% female subjects, p = 0.83) between the DM1 and healthy control cohorts. DM1 subjects had a mean disease duration of 21.3 AE 10.6 years and an average HbA1c of 7.7 AE 1.0. All patients were undergoing treatment with basal-bolus insulin. Nine eyes had no clinical signs of DR and 19 had mild NPDR.
OCT angiography findings
Parafoveal vessel density in the DCP was significantly reduced in the DM1 cohort compared to healthy controls (57.0 AE 3.3% versus 60.7 AE 2.4%, p < 0.001). There was no significant difference in parafoveal vessel density in the SCP between the two cohorts (49.8 AE 4.2% versus 51.5 AE 4.0%, p = 0.143). There was no significant difference in FAZ area in the DCP (0.40 AE 0.15 versus 0.38 AE 0.15 mm 2 , p = 0.510) or in the SCP (0.26 AE 0.12 versus 0.26 AE 0.11 mm 2 , p = 0.821) between DM1 eyes and controls. There was no significant correlation between DM1 duration or HbA1c and parafoveal vessel density in the DCP (r = À0.31, p = 0.114; r = À0.10, p = 0.614, respectively).
In the DCP, there was no significant difference in parafoveal vessel density e752 between diabetic patients with no DR and diabetic patients with mild NPDR (58.4 AE 2.9% versus 56.3 AE 3.3% p = 0.10). When comparing these subgroups to the control cohort, diabetic patients with mild NPDR had a significant reduction in DCP parafoveal vessel density (56.3 AE 3.3% versus 60.7 AE 2.4%, p < 0.001), while only a trend in the same direction was seen in diabetic patients with no DR group (58.4 AE 2.9% versus 60.7 AE 2.4%, p = 0.052) (Fig. 2) .
Discussion
In this study, we performed a crosssectional analysis of OCTA images obtained from a cohort of 28 DM1 patients with either no DR or mild NPDR. Compared to controls, this cohort had a decreased parafoveal vessel density in the DCP, while no difference was found in the SCP. As this DM1 cohort was limited to eyes with no or mild signs of diabetic retinopathy, these findings suggest that a decrease in parafoveal capillary density is an early process in the disease and occurs initially at the level of the DCP. Additionally, as there was no difference in FAZ area between cohorts, we can speculate that the decrease in parafoveal vessel density is most likely a result of diffuse capillary loss or nonperfusion, rather than FAZ enlargement or remodelling.
Multiple studies have used OCTA to study early vascular changes in DR. Freiberg et al. (2016) reported on FAZ diameter enlargement in DR, which was most pronounced in the DCP and correlated with visual acuity. Another study, which did not separate SCP and DCP, found an increase in FAZ area, FAZ remodelling, and areas of capillary nonperfusion, identified manually as focal points of decreased capillary density, in diabetic patients without clinical DR (de Carlo et al. 2015) . Unlike the present study, these reports investigated cohorts including both type 1 and type 2 DM patients. As type 1 DM patients with no or mild signs of DR are on average younger than type 2 DM patients and have a lower prevalence of comorbidities that may contribute to retinal vascular changes, including hypertension and dyslipidemia, a DM1-only cohort may be better suited to study retinal changes due specifically to the metabolic dysregulation of diabetes (Song 2015) .
Studies using FA techniques have demonstrated macular capillary nonperfusion in patients with no or mild DR (Arend et al. 1991; Sander et al. 1994 ). More recently, OCTA and analytic software have facilitated automated processing of macular perfusion data. Hwang et al. (2016a,b) described a similar decrease in vessel density in 12 DR eyes compared to healthy control; however, type 1 and type 2 DM patients were grouped for analysis, and all DR stages, including proliferative DR, were included. Therefore it is not surprising that a greater parafoveal vessel density decrease was found compared to that in our study (12.6% versus 3.7%), which excluded eyes with any sign of moderate or advanced DR.
As parafoveal vessel density could decrease from either diffuse capillary nonperfusion or FAZ extension into the parafoveal zone, it was important to measure FAZ area in the same cohort. The findings in this study most likely represent a diffuse reduction in capillary perfusion in the parafoveal area, as no difference was found in FAZ area between DM1 patients and healthy controls. This finding differs from other studies that have reported an early increase in FAZ area in diabetic populations; however, these cohorts were not restricted to DM1 patients, and parafoveal vessel density was not directly investigated Takase et al. 2016) . As both processes involve capillary dropout or nonperfusion in the macula, they may represent related processes involved in early diabetic-related vascular changes.
The decrease in parafoveal vessel density was isolated to the DCP in this cohort. Recently, some studies in DR have reported more prominent vascular changes in the DCP (Querques et al. 2014; Freiberg et al. 2016; Scarinci et al. 2016) , while others have found equal or greater involvement of the SCP (Agemy et al. 2015; Couturier et al. 2015) . These studies differ in the range of included DR severity and do not differentiate between type 1 and type 2 DM; therefore, it remains unknown whether initial involvement of the DCP is unique to DM1 patients. Multiple properties, including distance from the larger arterioles, proximity to the high metabolic demand of the outer retina, and the complex vascular anatomical architecture, may make the DCP more susceptible to diabetic damage (Nakahara et al. 2015) . Interestingly, retinal acidosis has been shown to be most prominent in the outer nuclear layer in the early stages of a diabetic retinopathy mouse model (Dmitriev et al. 2016) . Local acidosis can promote VEGF upregulation and increase leucostasis in small retinal capillaries (Tolentino et al. 1996; Campochiaro et al. 2014; Dmitriev et al. 2016) . None of these mechanisms is mutually exclusive, and more than one may be operating in DM1 patients.
One limitation of this study is the relatively small sample size. Additionally, we cannot exclude that projection from more superficial vasculature may be affecting these findings, particularly in the DCP, for either DM1 patients or control. It remains unclear how the influence of this artefact differs in normal and disease states (Coscas et al. 2016; Shahlaee et al. 2016) ; work is ongoing to better understand and correct for this artefact (Hwang et al. 2016b; Zhang et al. 2016) .
Optical coherence tomography angio -graphy (OCTA) vessel density reproducibility was not measured in this study; however, reproducibility and repeatability of macular perfusion measurements have been found to be very good in prior studies (Carpineto et al. 2016; Kim et al. 2016) . Longitudinal studies are needed to assess whether quantitative OCTA measurements can reliably be used to follow and predict DR progression.
In conclusion, we used quantitative OCTA measurements to demonstrate a parafoveal vessel density decrease, isolated to the DCP, in DM1 patients with no or mild DR compared to controls. This study raises multiple questions, and further investigation is needed to evaluate the clinical significance of early macular capillary changes in DM1 and the role of OCTA in early disease detection and management guidance in these patients.
